Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Latest news from the Kennedy Institute

New therapeutic target identified in spondyloarthritis

A new study published in Nature Communications identifies a key driver of joint and intestinal inflammation that could lead to future treatment of the chronic inflammatory disease.

Cancer progression may be controlled by targeting tumor-specific extracellular matrix

Researchers have uncovered how tumors exploit tenascin-C to deflect the body’s natural defence against them.

Researchers identify link in the treatment of inflammatory bowel disease (IBD)

A new study published in the Journal of Experimental Medicine reveals how IL-10 and PGE2 work together to prevent inflammatory tissue damage and maintain a healthy gut balance

NDORMS team awarded the International Dupuytren Award

Jagdeep Nanchahal, Professor of Hand, Plastic and Reconstructive Surgery at the Kennedy Institute, and his team have won the International Dupuytren Award for a trial repurposing anti-TNF in Dupuytren’s disease.

University of Birmingham Inflammation & Ageing Twitter